BUZZ-瑞穗上调 CVS Health PT 值,因其业务多元化

路透中文
Mar 14, 2025
BUZZ-瑞穗上调 CVS Health PT 值,因其业务多元化

3月14日 - ** 券商瑞穗将医疗保健集团CVS Health的CVS.NPT值从58美元上调至70美元,评级为 "跑赢大盘"。

** 新的目标价比该股收盘价上涨约 14

** 券商称,"鉴于其业务的多元化,CVS 是一个极具吸引力的投资机会"。

** 我们认为,CVS 调整后每股收益的长期增长底线取决于市场份额的增加和公司新的成本加成药房报销模式的成功"--券商补充道

** 29 家券商中有 18 家将该股评级为 "买入 "或更高,11 家为 "持有";他们的 PT 中值为 70.89 美元--数据由 LSEG 编制

** 在过去的 12 个月里,CVS 下跌了 12.4

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10